Cargando…
Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters
Andes virus (ANDV) is highly pathogenic in humans and is the primary etiologic agent of hantavirus cardiopulmonary syndrome (HCPS) in South America. Case-fatality rates are as high as 50% and there are no approved vaccines or specific therapies for infection. Our laboratory has recently developed a...
Autores principales: | Prescott, Joseph, DeBuysscher, Blair L., Brown, Kyle S., Feldmann, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939469/ https://www.ncbi.nlm.nih.gov/pubmed/24492621 http://dx.doi.org/10.3390/v6020516 |
Ejemplares similares
-
Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine
por: DeBuysscher, Blair L, et al.
Publicado: (2016) -
Comparison of the Pathogenicity of Nipah Virus Isolates from Bangladesh and Malaysia in the Syrian Hamster
por: DeBuysscher, Blair L., et al.
Publicado: (2013) -
Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters
por: Williamson, Brandi N., et al.
Publicado: (2021) -
Differential Innate Immune Responses Elicited by Nipah Virus and Cedar Virus Correlate with Disparate In Vivo Pathogenesis in Hamsters
por: Schountz, Tony, et al.
Publicado: (2019) -
Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus
por: Safronetz, David, et al.
Publicado: (2011)